Biogen

News

Alzheimer's drug Leqembi to launch at discount to Aduhelm

Eisai and Biogen's Alzheimer's therapy Leqembi will be priced at $26,500 per year – a little less than misfired predecessor Aduhelm – after getting conditional authorisation for the drug fr

News

Closeup of X-ray photography of human brain

Eisai questions link between lecanemab and patient death

With the FDA due to deliver a decision of Eisai and Biogen's new Alzheimer's disease candidate lecanemab tomorrow, the safety of the drug has been thrust into the spotlight by a case report

News

FDA "collaborated" with Biogen on Aduhelm approval, says inq...

The FDA's interactions with Biogen in the build-up to last year's controversial approval of Alzheimer's disease therapy Aduhelm have been described as "inappropriate" and "atypical" in a co

News

FDA slaps partial hold on Biogen, InnoCare MS drug

Biogen's efforts to replenish its multiple sclerosis pipeline have suffered a setback, after the FDA placed a clinical hold on a drug candidate it licensed from China's InnoCare last year f

News

Roche claims US approval for lymphoma bispecific Lunsumio

The FDA has given a green light to Roche's CD20xCD3 bispecific antibody Lunsumio as a treatment for relapsed or refractory follicular lymphoma, following the lead of the European Commission

News

x-ray image of human head with brain and electric pulses

ICER says lecanemab data in Alzheimer's "inconclusive"

One of the most highly-anticipated developments in pharma next year will be the FDA's verdict on Eisai's accelerated application for lecanemab in Alzheimer's disease, due early in January.<

Alzheimer's drug Leqembi to launch at discount to Aduhelm

Eisai questions link between lecanemab and patient death

FDA "collaborated" with Biogen on Aduhelm approval, says inq...

FDA slaps partial hold on Biogen, InnoCare MS drug

Roche claims US approval for lymphoma bispecific Lunsumio

ICER says lecanemab data in Alzheimer's "inconclusive"

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Biogen

Editor's Picks